Oppenheimer Downgrades Glaukos Corporation (GKOS) to Perform, Following Clinical Business Update
Tweet Send to a Friend
Oppenheimer analyst Steven Lichtman downgraded Glaukos Corporation (NYSE: GKOS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
